NA
Nascent Pharma Holdings, Inc.
NASC · OTC
$0.01 -13.94% (-$0.00)
1M +7.83%
Market Cap $910.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 107.66%
ROA 3,406.45%
Asset turnover 0.00x
Debt
50 /100
Moderate Current ratio 0.02x
Int. coverage -4.50x
Net debt/EBITDA -1.08x
Stability
55 /100
Moderate Beta 0.60x
Rev. volatility 76.26%
EPS volatility 15.06%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NASC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marco Alfonsi
Employees
12
Headquarters
Hicksville
Nadcházející události
06 LIS
Earnings
Upcoming earnings report